CareDx Reports Second Quarter 2023 Results
CareDx, Inc. – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and...
Stay updated with breaking news from Caredx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CareDx, Inc. – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and...
CareDx (NASDAQ:CDNA – Get Free Report) is scheduled to announce its earnings results after the market closes on Tuesday, August 8th. Analysts expect the company to announce earnings of ($0.56) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link. CareDx (NASDAQ:CDNA – […]
Shares of CareDx, Inc (NASDAQ:CDNA – Get Free Report) have earned an average recommendation of “Hold” from the five ratings firms that are currently covering the stock, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price objective […]
CareDx, Inc (NASDAQ:CDNA – Get Free Report) was up 6% during mid-day trading on Wednesday . The stock traded as high as $11.37 and last traded at $11.12. Approximately 182,932 shares were traded during trading, a decline of 84% from the average daily volume of 1,111,432 shares. The stock had previously closed at $10.49. Wall […]
CareDx, Inc (NASDAQ:CDNA – Get Free Report) insider Reginald Seeto sold 2,819 shares of CareDx stock in a transaction dated Wednesday, August 2nd. The shares were sold at an average price of $11.35, for a total transaction of $31,995.65. Following the transaction, the insider now directly owns 486,051 shares of the company’s stock, valued at […]